Prospective Molecular Characterization of Multiple Myeloma Patient Samples Identifies High-Risk Patients and Informs Treatment Sequences through Resistance Mechanisms to ImmunotherapiesPhillip Pham, Brian A. Walker, Marwan K. Tayeh et al.|Blood|2023Cited by 5
P535: The undiagnosed rare disease clinic program of Indiana University: Lessons learned from the first 100 patients enrolled (Phase-I pilot)Khurram Liaqat, Stephanie M. Ware, Francesco Vetrini et al.|Genetics in Medicine Open|2024Cited by 0
The Disproportional Burden of Multiple MyelomaMohamed H. Bikhet, Nichole LePage, Halimat Olaniyan et al.|Blood|2024Cited by 0
P626: Enhancing ultra-rare disease diagnoses through multi-omics integration and multi-site collaboration in the Indiana University Undiagnosed Rare Disease Clinic (URDC) cohortKhurram Liaqat, Francesco Vetrini, Kayla Treat et al.|Genetics in Medicine Open|2025Cited by 0
Diagnostic sequencing identifies high-risk markers and mechanisms of resistance to guide immunotherapy selectionParvathi Sudha, Brian A. Walker, Phillip Pham et al.|Blood Advances|2025Cited by 0